Wichtige Widerstände: Wo NVO jetzt scheitern könnte
1 extracted signal · 0 resolved · 0 still active
MCO Global AktienIndependent analyst profile- Source published
- 29 Jun 2026, 16:14 UTC
- Recorded by Tahlil Plus
- 15 Jul 2026, 15:02 UTC
AI-generated source summary
The analysis focuses on Novo Nordisk (NVO) with a bearish outlook on the 4-hour timeframe. The current price is observed at 48.03. The predicted target price is 21.82. The invalidation level, or fail bound, is set at 56.85. The analysis suggests that the price is currently in a corrective rally within a larger downtrend. The structure indicates a potential for a five-wave move downwards, with the third wave being the primary focus. Key support levels are identified around 41.70 and the swing low of 41.50. The resistance zone for a potential wave 2 bounce is between 50.00 and 56.85. If the price breaks above 56.85, the bearish outlook would be invalidated, and the analysis would need to be re-evaluated, possibly indicating a broader corrective rally. The immediate target for the bearish move is around 21.82, with further potential downside towards 17.40.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Source processing completed
Source analysis and structured extraction completed.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
MCO Global Aktien
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.